ArticleHuman gene therapy2010

Systemic delivery of an oncolytic adenovirus expressing soluble transforming growth factor-β receptor II-Fc fusion protein can inhibit breast cancer bone metastasis in a mouse model.

Zebin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.